| Literature DB >> 26209367 |
Xinfen Yu1, Yu Kou2, Daozong Xia3, Jun Li2, Xuhui Yang2, Yinyan Zhou2, Xiaoyan He2.
Abstract
BACKGROUND: Human respiratory syncytial virus (RSV) is the most important viral pathogen in children. However, its epidemic patterns and co-infection characteristics are not fully understood.Entities:
Keywords: Children; Co-infection; Epidemic pattern; Genotype; Human respiratory syncytial virus
Mesh:
Year: 2015 PMID: 26209367 PMCID: PMC7185398 DOI: 10.1016/j.jcv.2015.05.015
Source DB: PubMed Journal: J Clin Virol ISSN: 1386-6532 Impact factor: 3.168
Fig. 1Monthly distribution of RSV infections in ALRI (A) and ILI (B).
Subgroup distribution of RSV A and RSV B infections in children with ALRI or ILI from 2011 to 2013.
| Epidemic season | No. of samples | No. (%) of RSV positive samples | No. (%) of RSV cases by subgroup: | No. of RSV-A genotypes ( | No. of RSV-B genotypes ( | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RSV A | RSV B | ON1 | NA1 | NA3 | CB1 | BA10 | BA11 | ||||
| ALRI | 2011–2012 | 372 | 147(39.5) | 137(93.2) | 10(6.8) | 1 | 91 | 2 | 2 | 1 | 6 |
| 2012–2013 | 280 | 78(27.9) | 14(17.9) | 64(82.1) | 5 | 7 | 1 | 2 | 0 | 43 | |
| Total | 652 | 225(34.5) | 151(67.1) | 74(32.9) | 6 | 98 | 3 | 4 | 1 | 49 | |
| ILI | 2011–2012 | 582 | 17(2.9) | 16(94.1) | 1(5.9) | 0 | 4 | 0 | 0 | 0 | 0 |
| 2012–2013 | 586 | 26(4.4) | 2(7.7) | 24(92.3) | 0 | 0 | 0 | 0 | 0 | 2 | |
| Total | 1168 | 44(3.9) | 19(43.2) | 25(56.8) | 0 | 4 | 0 | 0 | 0 | 2 | |
Fig. 2Phylogenetic trees of RSV group A (A) and group B (B) nucleotide sequences from the second variable region of the G protein. Reference strains obtained from GenBank are marked with ◆.
Co-infection of RSV with other viruses and atypical bacteria.
| Viruses | No. of samples | Viruses | No. of samples | Viruses | No. of samples | |
|---|---|---|---|---|---|---|
| ALRI | RSV + HRV | 17 | RSV + ADV | 2 | RSV + SAFV + HMPV | 2 |
| RSV + HMPV | 12 | RSV + MP + CP | 3 | RSV + HRV + HMPV | 1 | |
| RSV + SAFV | 10 | RSV + HBoV | 1 | RSV + ADV + MP | 2 | |
| RSV + 229E | 5 | RSV + HMPV + Mp | 1 | RSV + ADV + HBoV | 1 | |
| RSV + PIV | 5 | RSV + HRV + PIV | 4 | RSV + PIV + ADV | 1 | |
| RSV + MP | 6 | RSV + Flu + HMPV | 2 | RSV + Flu + SAFV + MP | 1 | |
| RSV + Flu | 2 | RSV + HRV + HBoV | 2 | RSV + Flu + SAFV + ADV | 1 | |
| ILI | RSV + HRV | 1 | RSV + PIV | 1 | RSV + Flu | 2 |
82 Co-infections among 225 RSV positive samples in ALRI.
4 Co-infections among 44 RSV positive samples in ILI.
Comparison of clinical manifestations in the RSV Mono-infection group and co-infection group with ALRI
| Characteristic | No. (%) of patients in group with: | P value | |
|---|---|---|---|
| Mono-infection | Co-infection | ||
| Age(MO) | |||
| >12 | 127(88.8) | 65(79.3) | 0.051 |
| ≤12 | 16(11.2) | 17(20.7) | |
| Symptoms | |||
| Cough | 140(97.9) | 81(98.8) | 1.000 |
| Fever | 34(23.8) | 48(58.5) | 0.000 |
| Shortness of breath | 60(42.0) | 34(41.5) | 0.942 |
| Abnormality of lung Identified by X-ray | 117(81.8) | 71(86.6) | 0.353 |
| Congenital heart disease | 17(11.9) | 12(14.6) | 0.554 |
| Complication | |||
| Pneumonia | 123(86.0) | 76(92.7) | 0.132 |
| Respiratory failure | 10(7.0) | 7(8.5) | 0.673 |
| Hepatic insufficiency | 7(4.9) | 4(4.9) | 1.000 |
Chi-square test.
Continuity correction.